Chlorine in PDB 8dnj: Crystal Structure of Human Kras G12C Covalently Bound with Astrazeneca WO2020/178282A1 Compound 76
Enzymatic activity of Crystal Structure of Human Kras G12C Covalently Bound with Astrazeneca WO2020/178282A1 Compound 76
All present enzymatic activity of Crystal Structure of Human Kras G12C Covalently Bound with Astrazeneca WO2020/178282A1 Compound 76:
3.6.5.2;
Protein crystallography data
The structure of Crystal Structure of Human Kras G12C Covalently Bound with Astrazeneca WO2020/178282A1 Compound 76, PDB code: 8dnj
was solved by
C.Mohr,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
30.00 /
1.81
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
37.594,
112.162,
57.821,
90,
96.8,
90
|
R / Rfree (%)
|
23.9 /
28.9
|
Other elements in 8dnj:
The structure of Crystal Structure of Human Kras G12C Covalently Bound with Astrazeneca WO2020/178282A1 Compound 76 also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Crystal Structure of Human Kras G12C Covalently Bound with Astrazeneca WO2020/178282A1 Compound 76
(pdb code 8dnj). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 3 binding sites of Chlorine where determined in the
Crystal Structure of Human Kras G12C Covalently Bound with Astrazeneca WO2020/178282A1 Compound 76, PDB code: 8dnj:
Jump to Chlorine binding site number:
1;
2;
3;
Chlorine binding site 1 out
of 3 in 8dnj
Go back to
Chlorine Binding Sites List in 8dnj
Chlorine binding site 1 out
of 3 in the Crystal Structure of Human Kras G12C Covalently Bound with Astrazeneca WO2020/178282A1 Compound 76
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Crystal Structure of Human Kras G12C Covalently Bound with Astrazeneca WO2020/178282A1 Compound 76 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl303
b:25.4
occ:1.00
|
CL1
|
A:U4U303
|
0.0
|
25.4
|
1.0
|
C15
|
A:U4U303
|
1.7
|
25.9
|
1.0
|
C16
|
A:U4U303
|
2.7
|
26.7
|
1.0
|
C14
|
A:U4U303
|
2.7
|
25.1
|
1.0
|
C1
|
A:U4U303
|
3.1
|
24.5
|
1.0
|
F1
|
A:U4U303
|
3.5
|
23.0
|
1.0
|
C6
|
A:U4U303
|
3.5
|
23.4
|
1.0
|
O
|
A:TYR96
|
3.6
|
25.4
|
1.0
|
CG1
|
A:ILE100
|
3.8
|
26.9
|
1.0
|
CB
|
A:GLN99
|
3.9
|
30.5
|
1.0
|
CA
|
A:TYR96
|
3.9
|
23.6
|
1.0
|
C2
|
A:U4U303
|
4.0
|
24.2
|
1.0
|
C17
|
A:U4U303
|
4.0
|
26.2
|
1.0
|
C19
|
A:U4U303
|
4.0
|
26.2
|
1.0
|
CB
|
A:TYR96
|
4.0
|
22.7
|
1.0
|
CD1
|
A:TYR96
|
4.1
|
21.8
|
1.0
|
C
|
A:TYR96
|
4.2
|
24.5
|
1.0
|
CD1
|
A:ILE100
|
4.3
|
26.4
|
1.0
|
CG2
|
A:VAL9
|
4.3
|
16.3
|
1.0
|
C13
|
A:U4U303
|
4.4
|
25.5
|
1.0
|
CG
|
A:TYR96
|
4.4
|
22.0
|
1.0
|
N
|
A:ILE100
|
4.5
|
28.0
|
1.0
|
C18
|
A:U4U303
|
4.5
|
25.8
|
1.0
|
C5
|
A:U4U303
|
4.6
|
22.8
|
1.0
|
CB
|
A:VAL9
|
4.6
|
16.0
|
1.0
|
CG1
|
A:VAL9
|
4.7
|
16.4
|
1.0
|
C
|
A:GLN99
|
4.8
|
28.6
|
1.0
|
CG
|
A:GLN99
|
4.8
|
32.0
|
1.0
|
C3
|
A:U4U303
|
4.9
|
23.2
|
1.0
|
CA
|
A:GLN99
|
5.0
|
29.0
|
1.0
|
CB
|
A:ILE100
|
5.0
|
27.2
|
1.0
|
|
Chlorine binding site 2 out
of 3 in 8dnj
Go back to
Chlorine Binding Sites List in 8dnj
Chlorine binding site 2 out
of 3 in the Crystal Structure of Human Kras G12C Covalently Bound with Astrazeneca WO2020/178282A1 Compound 76
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Crystal Structure of Human Kras G12C Covalently Bound with Astrazeneca WO2020/178282A1 Compound 76 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl303
b:22.7
occ:1.00
|
CL1
|
B:U4U303
|
0.0
|
22.7
|
1.0
|
C15
|
B:U4U303
|
1.7
|
21.5
|
1.0
|
C16
|
B:U4U303
|
2.7
|
21.4
|
1.0
|
C14
|
B:U4U303
|
2.7
|
20.9
|
1.0
|
C1
|
B:U4U303
|
3.1
|
20.8
|
1.0
|
O
|
B:TYR96
|
3.5
|
23.4
|
1.0
|
C6
|
B:U4U303
|
3.5
|
21.0
|
1.0
|
F1
|
B:U4U303
|
3.6
|
21.1
|
1.0
|
CG1
|
B:ILE100
|
3.8
|
25.2
|
1.0
|
C2
|
B:U4U303
|
3.8
|
20.8
|
1.0
|
CA
|
B:TYR96
|
3.8
|
23.3
|
1.0
|
CB
|
B:GLN99
|
3.9
|
30.7
|
1.0
|
C17
|
B:U4U303
|
4.0
|
21.5
|
1.0
|
C19
|
B:U4U303
|
4.0
|
21.2
|
1.0
|
CB
|
B:TYR96
|
4.0
|
22.6
|
1.0
|
CD1
|
B:TYR96
|
4.1
|
21.8
|
1.0
|
C
|
B:TYR96
|
4.1
|
23.4
|
1.0
|
C13
|
B:U4U303
|
4.2
|
21.6
|
1.0
|
CD1
|
B:ILE100
|
4.3
|
25.1
|
1.0
|
N
|
B:ILE100
|
4.4
|
26.8
|
1.0
|
CG
|
B:TYR96
|
4.4
|
22.1
|
1.0
|
C18
|
B:U4U303
|
4.5
|
21.3
|
1.0
|
C5
|
B:U4U303
|
4.5
|
20.8
|
1.0
|
CB
|
B:VAL9
|
4.7
|
18.3
|
1.0
|
CG1
|
B:VAL9
|
4.7
|
18.7
|
1.0
|
CG2
|
B:VAL9
|
4.7
|
18.7
|
1.0
|
C3
|
B:U4U303
|
4.8
|
20.8
|
1.0
|
C
|
B:GLN99
|
4.8
|
28.5
|
1.0
|
C23
|
B:U4U303
|
4.9
|
21.8
|
1.0
|
CA
|
B:GLN99
|
4.9
|
29.5
|
1.0
|
CG
|
B:GLN99
|
4.9
|
31.6
|
1.0
|
CB
|
B:ILE100
|
4.9
|
25.5
|
1.0
|
CA
|
B:ILE100
|
5.0
|
26.2
|
1.0
|
|
Chlorine binding site 3 out
of 3 in 8dnj
Go back to
Chlorine Binding Sites List in 8dnj
Chlorine binding site 3 out
of 3 in the Crystal Structure of Human Kras G12C Covalently Bound with Astrazeneca WO2020/178282A1 Compound 76
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Crystal Structure of Human Kras G12C Covalently Bound with Astrazeneca WO2020/178282A1 Compound 76 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Cl303
b:37.6
occ:1.00
|
CL1
|
C:U4U303
|
0.0
|
37.6
|
1.0
|
C15
|
C:U4U303
|
1.7
|
35.9
|
1.0
|
C14
|
C:U4U303
|
2.7
|
35.4
|
1.0
|
C16
|
C:U4U303
|
2.7
|
36.5
|
1.0
|
C1
|
C:U4U303
|
3.0
|
35.1
|
1.0
|
C6
|
C:U4U303
|
3.4
|
34.2
|
1.0
|
F1
|
C:U4U303
|
3.4
|
35.0
|
1.0
|
O
|
C:TYR96
|
3.5
|
32.1
|
1.0
|
CA
|
C:TYR96
|
3.8
|
33.4
|
1.0
|
C2
|
C:U4U303
|
3.9
|
34.8
|
1.0
|
CB
|
C:TYR96
|
3.9
|
32.9
|
1.0
|
CG1
|
C:ILE100
|
4.0
|
33.9
|
1.0
|
C19
|
C:U4U303
|
4.0
|
36.0
|
1.0
|
CB
|
C:GLN99
|
4.0
|
36.7
|
1.0
|
CD1
|
C:TYR96
|
4.0
|
33.1
|
1.0
|
C17
|
C:U4U303
|
4.0
|
36.5
|
1.0
|
C
|
C:TYR96
|
4.1
|
33.1
|
1.0
|
C13
|
C:U4U303
|
4.3
|
35.9
|
1.0
|
CG1
|
C:VAL9
|
4.4
|
21.9
|
1.0
|
C5
|
C:U4U303
|
4.4
|
34.3
|
1.0
|
CG
|
C:TYR96
|
4.4
|
32.5
|
1.0
|
CB
|
C:VAL9
|
4.4
|
21.3
|
1.0
|
CD1
|
C:ILE100
|
4.4
|
33.5
|
1.0
|
C18
|
C:U4U303
|
4.5
|
36.1
|
1.0
|
CG2
|
C:VAL9
|
4.5
|
21.5
|
1.0
|
N
|
C:ILE100
|
4.6
|
34.7
|
1.0
|
CG
|
C:GLN99
|
4.7
|
38.2
|
1.0
|
C3
|
C:U4U303
|
4.8
|
34.7
|
1.0
|
SD
|
C:MET72
|
4.9
|
41.4
|
1.0
|
C
|
C:GLN99
|
4.9
|
34.9
|
1.0
|
C4
|
C:U4U303
|
5.0
|
34.1
|
1.0
|
|
Reference:
K.Zhu,
C.Li,
K.Y.Wu,
C.Mohr,
X.Li,
B.Lanman.
Modeling Receptor Flexibility in the Structure-Based Design of Kras G12C Inhibitors. J.Comput.Aided Mol.Des. V. 36 591 2022.
ISSN: ESSN 1573-4951
PubMed: 35930206
DOI: 10.1007/S10822-022-00467-0
Page generated: Tue Jul 30 08:49:01 2024
|